Navigation Links
Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online
Date:7/23/2008

Output of New Molecular Entities Drops to Historic Low as Pharma Companies

Face Increasing Competition from Generics Companies

LONDON, July 24 /PRNewswire/ -- The Scientific business of Thomson Reuters today announced the availability of the newly published CMR International 2008 Pharmaceutical R&D Factbook, an indispensable reference and business planning tool for decision makers in pharmaceutical R&D, corporate finance, business strategy, marketing planning and corporate communications. This year's Factbook offers a comprehensive and up-to-date overview of emerging trends in worldwide pharmaceutical R&D and has been considerably enhanced with data sourced from other Thomson Reuters businesses providing insight into areas such as generic drugs and patents.

CMR International's research shows that the output of new molecular entities (NMEs) fell to a new 20 year low despite continued year-on-year increases in R&D expenditure. The proportion of sales derived from products first launched within the last five years dropped to below 10%, leaving pharmaceutical companies open to the threat of patent expiry. As R&D companies are attempting to reverse the decline in the Pharma Industry's productivity, it is clear that competition from the generics sector is rapidly increasing. In particular, generics manufacturers in India are having an increased impact.

"The R&D Factbook has highlighted the challenges faced by the pharmaceutical industry, with a decrease in new drugs reaching the marketplace in 2007 and an increasing number of generics manufacturers expanding their capabilities to exploit expiring patents," said Alexander Karle, Vice President and General Manager of CMR International. "Our research shows that those companies best able to manage portfolio risk, drive efficiency through effective development and maximize the return from alliances and collaborations will be best placed to succeed in the coming years."

The information found in the Factbook is based on primary sources covering major pharmaceutical companies that account for approximately 80% of the industry's global R&D expenditure. The CMR International 2008 Pharmaceutical R&D Factbook is available as a hard copy report, or in single-user or enterprise-wide electronic format supplied on CD-ROM.

For further information and an opportunity to purchase the Factbook, please go to: http://www.techstreet.com/cgi-bin/joint.cgi/cmr

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to http://www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thomson Scientific Predicts Nobel Laureates
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
4. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Thomson Acquires Prous Science
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. Thomson Scientific Ranks Australian Universities and Research Institutes
9. Thomson Scientific Launches Confessions ... of a User Campaign Asking Are You the New Face of Research?
10. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
11. Thomson Healthcare Launches Application That Assesses Physician Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... The ... Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits and ... the District of Columbia as an education tool in the war against teen drug ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution of the latest ... readers to sign up as an organ donor for the 123,000 people in the ... organ donor can save up to 8 saves through organ donation and enhance many ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I had ... an inventor from Winchester, Va. "I thought that if the nebulizer had a more ... rather than fearing them." , He developed the patent-pending NEBY to avoid the need ...
(Date:12/8/2016)... ... 08, 2016 , ... The Florida Hospital Tampa Wound Healing ... Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute ... and facilities have earned this distinction. This is the second time the Florida ...
(Date:12/8/2016)... ... 2016 , ... ZyDoc , a New York-based medical ... Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” has ... usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ natural ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of ... offering. ... report forecasts the global optical transceiver market to grow at a ... report covers the present scenario and the growth prospects of the ... the report considers the revenue generated from the shipment of optical ...
(Date:12/9/2016)...  Harmar Mobility, LLC announced today that Steven E. Dawson has been ... of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... Harmar ... Mr. Dawson,s executive career includes leadership roles managing ... of industries. He brings to the company deep operational and leadership expertise, ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a ... to address severe, rare diseases, today announced that senior management will ... Success Healthcare Conference at the InterContinental Barclay Hotel in ... 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma is engaged ...
Breaking Medicine Technology: